How are Be Clear on Cancer campaigns evaluated?
Public Health England, Department of Health and NHS England collate and analyse a number of data sets relating to each campaign.
The evaluation metrics are carefully considered for each campaign. Where necessary or relevant, additional metrics are added to the evaluation plan.
Anecdotal feedback from a range of experts and colleagues from all levels of campaign activity is also regularly reviewed. All of this information is used to help shape and develop the Be Clear on Cancer programme of activity.
Who evaluates the Be Clear on Cancer campaigns?
Cancer Research UK was appointed in 2011 to help develop the evaluation framework for the Be Clear on Cancer programme, and to lead the evaluation of all campaigns that took place between 2011 and March 2013.
Reflecting new structures within the NHS, Public Health England became responsible for campaign evaluation of all campaigns implemented from 1 April 2013 onwards.
Department of Health and Public Health England reports
Following the Cancer Reform Strategy (2007) and Improving Outcomes: A Strategy for Cancer (2011), the Government set it's ambition to save an additional 5, 000 lives per year by 2014/15. The aim was to achieve this through earlier diagnosis and better access to treatment. The Department of Health (DH) started the awareness raising activity in 2010. Public Health England now leads on the programme of activity in partnership with DH and NHS England. Department of Health and Public Health England reports below:
Programme evaluation summary
Given the importance of contributing to the evidence base for early diagnosis, there is strong commitment to release information from this programme into the public domain on a regular basis. The evaluation summaries below, providing an overview of results across the campaigns, are a reflection of this commitment.
Results from the campaign evaluations have been presented at various conferences through poster and oral presentations:
The results of the 'breast cancer in women over 70' national campaign, outlining the impact on urgent GP referrals and cancer diagnoses were presented in a poster at the Public Health England (PHE) Cancer Outcomes Conference in June 2015.
The results for the two regional pilot campaigns for oesophago-gastric and ovarian cancers, outlining the impact on urgent GP referrals and cancer diagnoses were presented in a poster at the PHE Cancer Outcomes Conference in June 2015.
An early summary of results across a range of campaigns were presented at the Second NAEDI Research Conference in April 2013.
An analysis of results from 53 local projects funded in 2010/11 under the NAEDI initiative, many of which used Be Clear on Cancer campaign materials, was presented at the Second NAEDI Research Conference in April 2013 and at the PHE Cancer Outcomes Conference June 2013.
The local oesophago-gastric cancers pilot results were summarised for a poster at the Second PHE Cancer Outcomes Conference June 2013 and also at the PHE Cancer Outcomes Conference June 2013.
A summary of the ‘blood in pee’ regional campaign results was presented in a poster at the PHE Cancer Outcomes Conference June 2014 and at the NCRI Cancer Conference November 2014.
The regional and first national lung cancer campaign evaluation results were summarised in an oral presentation at the 2014 PHE Cancer Outcomes Conference.
Results from the first national lung cancer campaign focusing on the impact on diagnostic investigations, were presented at the Royal College of Radiologists Annual Scientific Meeting in September 2014. The conference abstract was published in Clinical Radiology.
A summary of the impact of a number of campaigns on GP attendance was presented at the Royal College of General Practitioners Annual Conference in September 2014.
An initial investigation into the impact of the ‘blood in pee’ and bowel campaigns on inequalities was presented in a poster at the Public Health England Annual Conference in September 2014. The poster abstract is available here.
Peer review publications
In March 2015, the British Journal of Cancer (BJC) published the second NAEDI supplement. The publication showcases a series of papers presenting current evidence on early diagnosis across the patient pathway.
View the full supplement
As part of the March 2015 BJC supplement, Moffat et al. (2015) investigated the impact of the Be Clear on Cancer national bowel and lung cancer campaigns. The paper looks at public awareness and GP attendance with symptoms highlighted in the campaigns on samples of the population subgrouped by gender, age and socioeconomic status.
Power and Wardle (2015) looked at existing data from the Cancer Awareness Measure (CAM) to examine the impact of the Be Clear on Cancer campaigns on public awareness of key symptoms of lung and bowel cancer and perceived barriers to seeing a doctor.
In December 2014, an evaluation of the regional and first national lung cancer campaign by Ironmonger et al. (2014) was also published in the BJC.